EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of a post‐donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study

Lois G Kim iD, Thomas Bolton, Michael J Sweeting, Steven Bell, Sarah Fahle, Amy McMahon, Matthew Walker, Eamonn Ferguson iD, Gail Miflin, David J Roberts, Emanuele Di Angelantonio, Angela M Wood

Transfusion · 2023

DOI: 10.1111/trf.17277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2023. Verfasst von Lois G Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Blood and Transplant Research Unit in Donor Health and Behaviour, Cambridge, UK. Hauptthemen laut MEDLINE: Blood Donation, Hemoglobins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Department of Health, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Deferrals due to low hemoglobin are time‐consuming and costly for blood donors and donation services. Furthermore, accepting donations from those with low hemoglobin could represent a significant safety issue. One approach to reduce them is to use hemoglobin concentration alongside donor characteristics to inform personalized inter‐donation intervals. Study Design and Methods We used data from 17,308 donors to inform a discrete event simulation model comparing personalized inter‐donation intervals using “post‐donation” testing (i.e., estimating current hemoglobin from that measured by a hematology analyzer at last donation) versus the current approach in England (i.e., pre‐donation testing with fixed intervals of 12‐weeks for men and 16‐weeks for women). We reported the impact on total donations, low hemoglobin deferrals, inappropriate bleeds, and blood service costs. Personalized inter‐donation intervals were defined using mixed‐effects modeling to estimate hemoglobin trajectories and probability of crossing hemoglobin donation thresholds.

Results

The model had generally good internal validation, with predicted events similar to those observed. Over 1 year, a personalized strategy requiring ≥90% probability of being over the hemoglobin threshold, minimized adverse events (low hemoglobin deferrals and inappropriate bleeds) in both sexes and costs in women. Donations per adverse event improved from 3.4 (95% uncertainty interval 2.8, 3.7) under the current strategy to 14.8 (11.6, 19.2) in women, and from 7.1 (6.1, 8.5) to 26.9 (20.8, 42.6) in men. In comparison, a strategy incorporating early returns for those with high certainty of being over the threshold maximized total donations in both men and women, but was less favorable in terms of adverse events, with 8.4 donations per adverse event in women (7.0, 10,1) and 14.8 (12.1, 21.0) in men.

Discussion

Personalized inter‐donation intervals using post‐donation testing combined with modeling of hemoglobin trajectories can help reduce deferrals, inappropriate bleeds, and costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonationHemoglobinsMaleHumansFemaleEnglandHematologic TestsBlood Donors

Stichwörter der Autor:innen

blood donationlow hemoglobin deferralpost-donation testingsimulation modeling

Substanzen

Hemoglobins

Autor:innen und Institutionen

  • Blood and Transplant Research Unit in Donor Health and Behaviour, Cambridge, UK.
  • Dept of Public Health & Primary Care, University of Cambridge, Cambridge, UK.
  • BHF Data Science Centre, Health Data Research, UK.
  • Dept of Health Sciences, University of Leicester, Leicester, UK.
  • Dept of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • School of Psychology, University of Nottingham, Nottingham, UK.

ORCID-Profile: Lois G Kim, Eamonn Ferguson

Förderung

  • Medical Research Council
  • Department of Health
  • British Heart Foundation
  • Wellcome Trust
  • National Institute for Health and Care Research

Zitieren

APA

Kim, L. G., Bolton, T., Sweeting, M. J., Bell, S., Fahle, S., McMahon, A., Walker, M., Ferguson, E., Miflin, G., Roberts, D. J., Di Angelantonio, E., & Wood, A. M. (2023). Impact of a post‐donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study. Transfusion. https://doi.org/10.1111/trf.17277

Vancouver

Kim LG, Bolton T, Sweeting MJ, Bell S, Fahle S, McMahon A, et al. Impact of a post‐donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study. Transfusion. 2023. doi:10.1111/trf.17277

BibTeX
@article{Kim2023,
  author = {Kim, Lois G and Bolton, Thomas and Sweeting, Michael J and Bell, Steven and Fahle, Sarah and McMahon, Amy and Walker, Matthew and Ferguson, Eamonn and Miflin, Gail and Roberts, David J and Di Angelantonio, Emanuele and Wood, Angela M},
  title = {Impact of a post‐donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17277}
}
Kostenlos starten →